Controversial BRCA1 allelotypes in commonly used breast cancer cell lines
- 8 July 2009
- journal article
- letter
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 119 (1) , 249-251
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Induction and processing of complex DNA damage in human breast cancer cells MCF-7 and nonmalignant MCF-10A cellsFree Radical Biology and Medicine, 2008
- BRCA1 Haploinsufficiency, but not Heterozygosity for a BRCA1-truncating Mutation, Deregulates Homologous RecombinationCell Cycle, 2007
- BRCA1 Suppresses Osteopontin-mediated Breast CancerJournal of Biological Chemistry, 2006
- Development and applications of a real-time quantitative RT-PCR method (QRT-PCR) for BRCA1 mRNAClinical Biochemistry, 2005
- Karyotypic complexity of the NCI-60 drug-screening panel.2003
- Mutagen Sensitivity of Human Lymphoblastoid Cells with a BRCA1 MutationBreast Cancer Research and Treatment, 2003
- c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cellsOncogene, 2001
- Prolactin-Dependent Up-Regulation ofBRCA1Expression in Human Breast Cancer Cell LinesBiochemical and Biophysical Research Communications, 1999
- Growth retardation and tumour inhibition by BRCA1Nature Genetics, 1996
- BRCA1 overexpression sensitizes cancer cells to lovastatin via regulation of cyclin D1-CDK4-p21WAF1/CIP1 pathway: analyses using a breast cancer cell line and tumoral xenograft modelInternational Journal of Oncology, 1992